Skip to main navigation Skip to search Skip to main content

Whole-body 18FDG PET-CT imaging of systemic sarcoidosis: Ophthalmic oncology and uveitis

  • Julia P. Shulman
  • , Paul Latkany
  • , Kimberly J. Chin
  • , Paul T. Finger

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Abstract

Purpose: To describe whole-body 18-fluorodeoxyglucose (FDG) positron emission tomography/computed radiographic tomography (PET-CT) imaging of ophthalmic patients with systemic sarcoidosis. Methods: Four systemic sarcoidosis patients were evaluated with PET-CT for staging. Two had been treated for conjunctival melanoma and two had been referred for atypical choroidal tumors. PET-CT images were studied for presence of tumor or tissue with increased standardized uptake values, indicating increased metabolic activity. Results: In all cases, PET-CT revealed focal systemic lesions with increased uptake (SUV range 1.7-5.9 kg/mL). Cases 1 and 2 had a previous diagnosis of sarcoidosis (without ocular involvement), while cases 3 and 4 were diagnosed during their work-up. PET-CT revealed the presence and distribution of systemic sarcoid granulomas. Conclusions: In this series, PET-CT staged patients with eye cancer and systemic sarcoidosis and aided in differentiating between a metastatic choroidal tumor and uveal sarcoid granuloma. PET-CT offers a method to assess the presence and distribution of systemic sarcoidosis.

Original languageEnglish
Pages (from-to)95-100
Number of pages6
JournalOcular Immunology and Inflammation
Volume17
Issue number2
DOIs
StatePublished - Apr 2009
Externally publishedYes

Keywords

  • Choroid
  • Eye
  • FDG
  • Imaging
  • PET/CT
  • Sarcoidosis

Fingerprint

Dive into the research topics of 'Whole-body 18FDG PET-CT imaging of systemic sarcoidosis: Ophthalmic oncology and uveitis'. Together they form a unique fingerprint.

Cite this